CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
to conduct analysis of basal-bolus insulin detemir/aspart in comparison with the NPH/human insulin for the treatment of patients with diabetes mellitus type 1 in Russia. We evaluate results of PREDICTIVE study using pharmacoeconomic analyses: «cost – effectiveness,» «cost – utility» and « budget imp...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IRBIS LLC
2015-03-01
|
| Serija: | Фармакоэкономика |
| Teme: | |
| Online pristup: | https://www.pharmacoeconomics.ru/jour/article/view/40 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|